Pudendal Neuropathy Diagnosis and Management

Clinical Presentation and Diagnosis

The American Gastroenterological Association recommends anorectal manometry to evaluate for associated defecatory disorders, as excessive straining often coexists with pelvic floor dyssynergia 1, 2
The British Journal of Neurosurgery suggests ruling out cauda equina syndrome (CES), particularly incomplete CES (CESI), which presents with reduced bladder/urethral sensation and sexual dysfunction 3
The Journal of Urology recommends distinguishing from neurogenic lower urinary tract dysfunction (NLUTD) from other causes (spinal cord injury, multiple sclerosis, diabetes), which would have additional neurological findings 4, 5

The American Urological Association suggests addressing the underlying constipation and straining mechanism, and evaluating for defecatory disorders using anorectal manometry 1, 2
The American College of Gastroenterology recommends implementing behavioral modifications, such as adequate hydration, dietary fiber, and avoidance of prolonged straining 1, 6
The Journal of Urology suggests initiating neuropathic pain medication algorithm, even without pain, as these agents treat nerve dysfunction, starting with tricyclic antidepressants (nortriptyline or desipramine) at low doses 7, 6
The American College of Physicians recommends pelvic floor physical therapy with specific modifications, including manual physical therapy targeting pelvic floor trigger points, muscle contractures, and scar tissue, and avoiding standard Kegel exercises 7, 8

The Journal of Urology recommends clean intermittent catheterization (CIC) if significant post-void residual develops, and antimuscarinics (oxybutynin) or beta-3 agonists for storage symptoms if they develop 4, 5, 9
The American Urological Association suggests measuring post-void residual with portable ultrasound to avoid infection risk from catheterization 10

The British Journal of Neurosurgery notes that sexual dysfunction may persist even with successful treatment of other symptoms, particularly if genital sensory loss was present preoperatively 3
The American Gastroenterological Association recommends monitoring for progression with serial sensory examinations and functional assessments, and coordinating management of both conditions if pre-existing fistula is present 1

The initial evaluation should start with a focused digital rectal examination to identify signs of pudendal neuropathy, followed by anorectal manometry and pudendal nerve terminal motor latency (PNTML) testing to objectively assess sphincter function and nerve conduction. 11

Light pinprick or scratch of the perianal skin (anal reflex) evaluates superficial sensory pathways, which may remain intact even when deeper proprioceptive and motor pathways supplied by the pudendal nerve are impaired. 11
Observation of perineal descent greater than 3 cm during simulated defecation suggests chronic straining injury that can stretch the pudendal nerve. 11
A patulous (gaping) anal opening observed during simulated defecation is a strong indicator of neurogenic dysfunction of the external anal sphincter. 11

A normal mean PNTML does not rule out pudendal neuropathy; each side must be evaluated separately because unilateral latency prolongation can be missed when only the average is considered. 11
A normal digital rectal examination does not exclude pelvic floor dysfunction or pudendal neuropathy; objective testing should be pursued when clinical suspicion remains high. 11
Acute localized tenderness over the puborectalis muscle points to levator ani syndrome rather than pudendal neuropathy and should not be misinterpreted as nerve injury. 11

Dextranomer microspheres in hyaluronic acid (NASHA Dx) is the sole FDA‑approved injectable bulking agent for fecal incontinence; in clinical trials, 52 % of patients achieved a ≥ 50 % reduction in incontinence episodes after 6 months. 12

Sacral nerve stimulation, targeting the S2‑S4 nerve roots that innervate the external anal sphincter, is recommended after failure of conservative measures. 12
The protocol begins with a test stimulation period of 2–3 weeks; if incontinence frequency declines by ≥ 50 %, a permanent implant is indicated. 12
Long‑term data show 89 % therapeutic success at 5 years in selected patients with intact sphincter anatomy. 12